Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FCNAQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $65,633
Award facts
- Contract value 100% obligated
- $65,633.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price delivery order valued at $65,633.20 for Keytruda (pembrolizumab) 100 mg/4 ml vials. The contract was awarded on September 16, 2025, with an ultimate completion date of October 7, 2025, and does not utilize a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide.
Keytruda is an immunotherapy medication used in oncology treatments, consistent with DMS Pharmaceutical Group's established portfolio of supplying specialized pharmaceutical products to military health facilities. The company's proven track record of delivering complex medications and biologics to federal healthcare systems positions it as a critical supplier within the Defense Logistics Agency's pharmaceutical supply chain, ensuring that military medical facilities have access to essential cancer treatment medications and other specialized pharmaceuticals required to support troops and beneficiaries globally.
Quick answers
Who was awarded contract SPE2DB25FCNAQ?
SPE2DB25FCNAQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FCNAQ worth?
The government has obligated $65,633 on SPE2DB25FCNAQ.
Is contract SPE2DB25FCNAQ an order under another contract?
Yes. SPE2DB25FCNAQ is a delivery order under SPE2DB24D9144, an indefinite delivery contract.
Was contract SPE2DB25FCNAQ competed?
The extent of competition for SPE2DB25FCNAQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award